Thomas W. Dubensky's Net Worth

$6.95 Million

Estimate Recalculated Sep 8, 2024 07:37PM EST

Who is Thomas W. Dubensky?

Thomas W. Dubensky has an estimated net worth of $6.95 Million. This is based on reported shares across multiple companies, which include ADURO BIOTECH, INC., Millendo Therapeutics, Inc., and HTG MOLECULAR DIAGNOSTICS, INC.

SEC CIK

Thomas W. Dubensky's CIK is 0001635590

Past Insider Trading and Trends

2016 was Thomas W. Dubensky's most active year for acquiring shares with 18 total transactions. Thomas W. Dubensky's most active month to acquire stocks was the month of May. 2017 was Thomas W. Dubensky's most active year for disposing of shares, totalling 26 transactions. Thomas W. Dubensky's most active month to dispose stocks was the month of November. 2016 saw Thomas W. Dubensky paying a total of $234,922.35 for 264,800 shares, this is the most they've acquired in one year. In 2017 Thomas W. Dubensky cashed out on 600,000 shares for a total of $3,193,213.18, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ADURO BIOTECH, INC. No price found

Chief Scientific Officer

Thomas W. Dubensky owns 39,900 units of Common Stock. In the year 2015 Thomas W. Dubensky filed a total of 22 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$6.19
-$519,203.48
39.9K
Scheduled
Aug 10 - Aug 11
Form 4
—
0
$5.93
-$540,637.58
39.9K
Scheduled
Jul 3 - Jul 6
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
$5.28
-$1,372,740.47
39.9K
Scheduled
Jun 1 - Jun 5
Form 4
—
0
$5.22
-$53,564.15
39.9K
Scheduled
May 11 - May 12
Form 4
—
0
$5.87
-$254,631.67
39.9K
Scheduled
Mar 9
Form 4
—
0
$5.84
-$265,990.00
39.9K
Scheduled
Jan 3
Form 4
—
0
—
—
0
Dec 12
Form 4
—
0
$5.99
-$247,607.41
39.9K
Scheduled
Dec 1
Form 4
—
0
$8.04
-$336,819.84
39.9K
Scheduled
Nov 10
Form 4
—
0
$6.89
-$289,470.18
39.9K
Scheduled
Oct 3
Form 4
∞
39.9K
—
—
39.9K
Sep 12
Form 4
—
0
$7.58
-$322,516.49
0
Scheduled
Sep 1
Form 4
—
0
$8.08
-$354,875.00
0
Scheduled
Aug 11
Form 4
—
0
$6.32
-$264,286.73
0
Scheduled
Jul 5
Form 4
—
0
—
—
0
Jun 10
Form 4
-100.00%
-905.00
$8.20
-$7,421.00
0
Scheduled
May 16
Form 4
—
0
$15.53
-$325,372.77
0
Scheduled
Jan 4
Form 4
—
0
—
—
0
Dec 10
Form 4
—
0
$15.71
-$813,731.48
0
Scheduled
Dec 1
Form 4
-100.00%
-1.47K
$14.86
-$846,055.80
0
Scheduled
Nov 16 - Nov 17
Form 3
—
0
—
—
0
No matching records found

Millendo Therapeutics, Inc. (TPST) Snapshot price: $1.25

President

Thomas W. Dubensky owns 113,343 units of Common Stock which is worth $141,678.75. In the year 2021 Thomas W. Dubensky filed a total of 6 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jun 21
Form 4
+1.80%
2K
$4.78
$9,560.00
113.34K
Jan 7
Form 4
—
0
—
—
0
Jan 4
Form 4
∞
111.34K
—
—
111.34K
Jun 25
Form 3
—
0
—
—
0
No matching records found

HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ) Snapshot price: $0.41

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 18
Form 3
—
0
—
—
0
No matching records found